| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.0M | +20.0% |
| Cost of Revenue | $4.8M | -24.6% |
| R&D Expense | $5.9M | -58.4% |
| SG&A Expense | $24.5M | -20.8% |
| Operating Income | -$44.5M | +35.3% |
| Interest Expense | $45K | -92.4% |
| Pre-tax Income | $28.4M | +135.9% |
| Net Income | $39.8M | +162.0% |
| EPS (Basic) | $3.30 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -94.0% |
| Accounts Receivable | $18K | -70.5% |
| Inventory | $278K | +0.0% |
| Current Assets | $2.2M | -91.2% |
| Total Assets | $30.7M | -7.4% |
| Current Liabilities | $35.4M | -34.6% |
| Total Liabilities | $37.7M | -34.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.6M | +35.5% |
| Capital Expenditures | $55K | -77.3% |
| Investing Cash Flow | -$16.2M | -2235.1% |
| Financing Cash Flow | $31.3M | +0.4% |
| Free Cash Flow | -$33.6M | +35.7% |
| +136.0% |
| EPS (Diluted) | $0.50 | +105.5% |
| Stockholders' Equity |
| -$2.5M |
| +95.4% |